【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 24
2.1 Catalyst 24
2.2 Related Reports 25
2.3 Upcoming Related Reports 25
3 Disease Overview 26
3.1 Etiology and Pathophysiology 26
3.1.1 Etiology 26
3.1.2 Pathophysiology and Histology 26
3.1.3 NSCLC Biomarkers 27
3.1.4 Quality of Life 28
3.2 Symptoms 29
4 Epidemiology 31
4.1 Risk Factors and Comorbidities 32
4.1.1 Smokers are more likely to have lung cancer than non-smokers 33
4.1.2 Long-term exposure to radon increases the risk of lung cancer 35
4.1.3 Family history of any cancer increases lung cancer risk 35
4.1.4 TB increases the risk of lung cancer and increases mortality risk 35
4.1.5 COPD is a comorbidity that reduces lung cancer survival 36
4.1.6 Lung cancer screening programs may not be beneficial 36
4.1.7 Stage at diagnosis significantly impacts the survival of lung cancer cases 37
4.2 Global Trends 38
4.2.1 US 41
4.2.2 France 46
4.2.3 Germany 47
4.2.4 Italy 49
4.2.5 Spain 51
4.2.6 UK 53
4.2.7 Japan 54
4.2.8 China 56
4.2.9 India 58
4.3 Forecast Methodology 60
4.3.1 Sources Used 62
4.3.2 Sources Not Used 67
4.3.3 Forecast Assumptions and Methods 67
4.4 Epidemiology Forecast (2012-2022) 70
4.4.1 Incident/Prevalent Cases of NSCLC 70
4.4.2 Age-Specific Incident Cases of NSCLC 72
4.4.3 Sex-Specific Incident Cases of NSCLC 73
4.4.4 Age-Standardized Incidence Rates of NSCLC 75
4.4.5 Segmentation of NSCLC Incident Cases 76
4.5 Discussion 84
4.5.1 Limitations of the Analysis 85
4.5.2 Strengths of the Analysis 86
5 Disease Management 87
5.1 Treatment Overview 87
5.1.1 Diagnosis 88
5.1.2 Clinical Staging 89
5.1.3 Screening and Early Detection 91
5.1.4 Localized Procedures and Therapies 92
5.1.5 Systemic Chemotherapy 93
5.1.6 Targeted Therapy 93
5.2 US 96
5.2.1 Diagnosis 96
5.2.2 Clinical Practice 96
5.3 France 98
5.3.1 Diagnosis 98
5.3.2 Clinical Practice 99
5.4 Germany 100
5.4.1 Diagnosis 100
5.4.2 Clinical Practice 101
5.5 Italy 103
5.5.1 Diagnosis 103
5.5.2 Clinical Practice 104
5.6 Spain 105
5.6.1 Diagnosis 105
5.6.2 Clinical Practice 105
5.7 UK 106
5.7.1 Diagnosis 106
5.7.2 Clinical Practice 107
5.8 Japan 108
5.8.1 Diagnosis 108
5.8.2 Clinical Practice 109
5.9 China 110
5.9.1 Diagnosis 110
5.9.2 Clinical Practice 111
5.10 India 112
5.10.1 Diagnosis 112
5.10.2 Clinical Practice 112
6 Competitive Assessment 115
6.1 Overview 115
6.2 Strategic Competitor Assessment 116
6.3 Product Profiles – Major Brands, Chemotherapies 118
6.3.1 Alimta (pemetrexed disodium) 118
6.3.2 Abraxane (nab-paclitaxel) 123
6.4 Product Profiles – Major Brands, Targeted Therapies 127
6.4.1 Avastin (bevacizumab) 127
6.4.2 Gilotrif (afatinib) 132
6.4.3 Iressa (gefitinib) 138
6.4.4 Tarceva (erlotinib hydrochloride) 143
6.4.5 Xalkori (crizotinib) 149
7 Opportunity and Unmet Need 156
7.1 Overview 156
7.2 Improved Overall Survival and Less Toxicity 157
7.3 Treatments for Patients with Acquired TKI Resistance 158
7.4 Better Treatment Options for Squamous Patients 158
7.5 Preventing Relapse or Recurrence 159
7.6 More Efficacious Second-Line Therapies 159
7.7 Increased Availability of Mutation Testing 160
7.8 More Cost-Effective Therapies 160
7.9 Unmet Needs Gap Analysis 161
8 Pipeline Assessment 165
8.1 Overview 165
8.2 Clinical Trial Mapping 165
8.2.1 Clinical Trials by Country 165
8.3 Clinical Trials by Phase and Trial Status 167
8.4 Promising Drugs in Clinical Development 168
8.4.1 Onartuzumab (MetMab) 172
8.4.2 Necitumumab (IMC-11F8) 177
8.4.3 Ramucirumab (IMC-1121B) 183
8.4.4 Custirsen (OGX-011) 188
8.4.5 Ganetespib (STA-9090) 194
8.4.6 Nintedanib (BIBF1120) 201
8.4.7 Dacomitinib (PF-00299804) 206
8.4.8 LDK378 (ceritinib) 211
8.4.9 Yervoy (ipilimumab) 217
8.4.10 Nivolumab (BMS936558) 222
8.4.11 MPDL3280A (RG7446) 230
8.4.12 GSK1572932A (MAGE-A3 Cancer Immunotherapy) 233
8.4.13 Halaven (eribulin mesylate) 237
9 Current and Future Players 243
9.1 Overview 243
9.2 Trends in Corporate Strategy 245
9.3 Company Profiles 246
9.3.1 Roche/Genentech 246
9.3.2 Pfizer 249
9.3.3 Bristol-Myers Squibb 251
9.3.4 Eli Lilly 254
9.3.5 Boehringer Ingelheim 257
9.3.6 Novartis 259
10 Market Outlook 261
10.1 Global Markets 261
10.1.1 Forecast 261
10.1.2 Drivers and Barriers – Global Issues 265
10.2 United States 269
10.2.1 Forecast 269
10.2.2 Key Events 273
10.2.3 Drivers and Barriers 274
10.3 France 277
10.3.1 Forecast 277
10.3.2 Key Events 281
10.3.3 Drivers and Barriers 282
10.4 Germany 284
10.4.1 Forecast 284
10.4.2 Key Events 288
10.4.3 Drivers and Barriers 289
10.5 Italy 291
10.5.1 Forecast 291
10.5.2 Key Events 295
10.5.3 Drivers and Barriers 295
10.6 Spain 297
10.6.1 Forecast 297
10.6.2 Key Events 300
10.6.3 Drivers and Barriers 301
10.7 United Kingdom 302
10.7.1 Forecast 302
10.7.2 Key Events 306
10.7.3 Drivers and Barriers 307
10.8 Japan 309
10.8.1 Forecast 309
10.8.2 Key Events 313
10.8.3 Drivers and Barriers 313
10.9 China 316
10.9.1 Forecast 316
10.9.2 Key Events 320
10.9.3 Drivers and Barriers 320
10.10 India 323
10.10.1 Forecast 323
10.10.2 Key Events 327
10.10.3 Drivers and Barriers 327
11 Appendix 329
11.1 Bibliography 329
11.2 Abbreviations 360
11.3 Methodology 365
11.4 Forecasting Methodology 365
11.4.1 Number of NSCLC Patients Currently Seeking Treatment 365
11.4.2 Percent Drug-Treated Patients 366
11.4.3 Drugs Included in Each Therapeutic Class 366
11.4.4 Launch and Patent Expiry Dates 367
11.4.5 General Pricing Assumptions 368
11.4.6 Individual Drug Assumptions 371
11.4.7 Generic Erosion 381
11.4.8 Pricing of Pipeline Agents 381
11.5 Physicians and Specialists Included in This Study 383
11.6 Survey of Prescribing Physicians 385
11.7 About the Authors 386
11.7.1 Authors 386
11.7.2 Epidemiologists 387
11.7.3 Global Head of Healthcare 388
11.8 About GlobalData 389
11.9 Disclaimer 389
【レポート販売概要】
■ タイトル:非小細胞肺がん:グローバル医薬品市場(~2022)■ 英文:PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
■ 発行日:2014年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC002EPIDR
■ 調査対象地域:グローバル
- 世界のPasta & Noodles市場におけるニュース・イベント動向(2014年2月)Synopsis The report provides a review of the latest news and key events in the global pasta & noodles market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global pasta & noodles market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events …
- 潤滑添加剤のグローバル市場(~2019)Lubricant additives can be categorized into ten major types based on their functions, which are dispersants, viscosity index improvers, detergents, antiwear, antioxidants, corrosion inhibitors, emulsifiers, friction modifiers, EP, PPDs, and others. These are made of raw material/ chemicals such as poly amines, phenols, olefin, maleic anhydride, and others. Lubricant additives find their usage in v …
- 黄斑変性症(AMD)及びその他の網膜疾患治療薬の世界市場AMD and Other Retinal Diseases – our new study reveals trends, R&D progress, and predicted revenuesWhere is the AMD and Other Retinal Diseases market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our …
- 水・廃水処理設備の世界市場分析:製品別(膜分離、消毒、スラッジ)、技術別(一次治療、二次治療、三次治療)、用途別、セグメント予測、2014-2025The global water & wastewater treatment equipment market size is expected to reach approximately USD 103.41 billion by 2025, according to a new report conducted by Grand View Research, Inc. The rising demand for fresh water mainly owing to population explosion and industrialization across the globe is estimated to amplify the market growth over the years ahead. This, in turn, is projected to enhan …
- 3Dセンサの世界市場:画像センサ、ポジションセンサ、音響センサ、加速度センサThe 3D sensormarket report analyzes the ecosystem of the 3D sensor technology; and the market segmented on the basis oftechnology includesstereo vision, structured light, time of flight, and ultra sound. The report also provides the geographic view for the major regions,namely,North America, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW). It also discusses the burning issues, market …
- 世界のパワートレインセンサー市場:ICE車両用センサー種類別(位置、圧力、速度、温度)、EV用センサー種類別(位置、温度、電流、電圧)、推進別、パワートレインサブシステム別、車両タイプ別、EVタイプ別、地域別“Increasing adoption of vehicles equipped with modern ICE drivetrain and HEVs are anticipated to trigger the growth of the powertrain sensor market.” The global powertrain sensor market is projected to grow at a CAGR of 2.8% to reach USD 24.7 billion by 2027, from an estimated USD 19.8 billion in 2019. Increasing adoption of powertrain sensors required for better fuel economy and decrease in carbo …
- 抗生物質の世界市場:画期的医薬品の市場機会及び商用化Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation Summary An Extensive Developmental Pipeline, but Limited First in Class Innovation The antibiotics pipeline is very active, with 741 products in development. Of these, the majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the ear …
- ヘルスケアにおけるRTLS(リアルタイム位置情報システム)の世界市場予測(~2023年)“The real-time locating systems (RTLS) market for healthcare to grow at a CAGR of 18.3% during the forecast period”The RTLS market for healthcare is expected to grow from USD 1,271.2 million in 2018 to USD 2,941.2 million by 2023, at a CAGR of 18.3% during the forecast period. The increased competitiveness in the market with the emergence of startups providing innovative and customized RTLS soluti …
- 有毛細胞白血病:世界の臨床試験レビュー(2014年上半期)Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Hairy Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hairy Cell Leukemia. It includes an overview of the trial numbers and their recru …
- 軍事用浮き橋の世界市場2016-2020About the Military Floating Bridge Market Military floating bridges primarily include ribbon bridges and self-propelled floating bridges. The ground military personnel and the marine forces use these for missions, including sheltered water and river crossings in combat and rescue operations. These bridges can also be utilized for the transportation and mobilization of cargo and supplies and combat …
- インドの石油・ガス産業における中流(Midstream)市場展望India Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "India Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in India. The report provides oil prod …
- 世界のタッチスクリーン市場(市場予測、機会、トレンド2013-2016)With the growth of tablet PCs and smartphones the global industry for touchscreens has witnessed substantial growth. A touchscreen detects and locates and touch over a display area. The touchscreen is sensitive to the touch of human fingers or even passive objects such as a stylus. Touchscreen displays are being used widely in computers, iPads, gaming consoles, PDAs, tablets, smartphones, public k …
- コルポスコープ(膣拡大鏡)の世界市場2017-2021About Colposcopes The global colposcopes market is dominated by the Americas, followed by EMEA and APAC. In 2016, the US was the leading revenue generator in the market. The market is witnessing faster growth because of the advances in technology, as clinics and hospitals are more inclined to purchase advanced systems for improved diagnosis. Technavio’s analysts forecast the global colposcopes mar …
- がん用バイオマーカーの世界市場予測(~2022年):タンパク質バイオマーカー、遺伝子バイオマーカーThe global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and …
- 浴室付属品の世界市場:流通経路別、地域別Global Bathroom Accessories Market: About this market Technavio’s bathroom accessories market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of bathroom accessories in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend is expected to continue over the forecast …